BRIEF published on 04/29/2025 at 07:35, 1 year 4 months ago Symrise Reports Solid Q1 Growth and Confirms Year-End Targets EBITDA Margin Organic Growth Market Expansion Taste And Scent ONE Symrise Strategy
PRESS RELEASE published on 04/29/2025 at 07:30, 1 year 4 months ago Symrise delivers solid growth in Q1 and reaffirms outlook Symrise AG reports solid Q1 growth with organic growth of 4.2% and reaffirms 2025 outlook, driven by higher volumes. Strategic assessment of Chemicals Production activities conducted Organic Growth Symrise AG Q1 Growth 2025 Outlook Chemicals Production
BRIEF published on 03/27/2025 at 07:35, 1 year 5 months ago Symrise augmente son dividende et confirme ses objectifs de croissance Stratégie De Croissance Symrise AG Rapport Annuel 2024 Augmentation Des Dividendes Initiatives De Développement Durable
BRIEF published on 03/27/2025 at 07:35, 1 year 5 months ago Symrise Increases Dividend and Confirms Growth Targets Growth Strategy Dividend Increase Symrise AG Sustainability Initiatives Annual Report 2024
PRESS RELEASE published on 03/27/2025 at 07:30, 1 year 5 months ago Symrise raises dividend and confirms outlook Symrise AG raises dividend to € 1.20 per share for 2024, confirms 2025 outlook with 5-7% organic growth target and 21% EBITDA margin, extends Executive Board contract Organic Growth Dividend Increase Symrise AG 2025 Outlook Executive Board Contract Extension
BRIEF published on 02/21/2025 at 10:20, 1 year 6 months ago Symrise s'associe à HBC pour améliorer ses offres en matière de santé et de nutrition Durabilité Nutrition Santé Symrise Partenariat HBC Ingrédients Marins
BRIEF published on 02/21/2025 at 10:20, 1 year 6 months ago Symrise Partners with HBC to Enhance Health and Nutrition Offerings Sustainability Symrise HBC Partnership Marine Ingredients Health Nutrition
PRESS RELEASE published on 02/21/2025 at 10:15, 1 year 6 months ago Symrise accelerates in Human Health and Pet Nutrition through a strategic partnership with HBC Symrise accelerates in Human Health and Pet Nutrition with strategic partnership with HBC, expanding into clinically proven marine ingredients for health and nutrition markets Strategic Partnership Pet Nutrition Symrise Human Health HBC
BRIEF published on 01/30/2025 at 07:35, 1 year 7 months ago Symrise annonce une forte croissance de ses ventes et de ses bénéfices pour 2024 Croissance Des Bénéfices Résultats Financiers 2024 Augmentation Des Ventes Marchés Mondiaux Symrise
BRIEF published on 01/30/2025 at 07:35, 1 year 7 months ago Symrise Reports Robust Sales and Profit Growth for 2024 Sales Increase Global Markets Profit Growth 2024 Financial Results Symrise
Published on 09/11/2026 at 13:00, 49 minutes ago Silver Tiger Intersects 2.1 Metres of 7.72 Kilograms Per Tonne Silver Equivalent in the Caleigh Vein Including 0.53 Metres of 29.62 Kilograms
Published on 09/11/2026 at 04:00, 9 hours 49 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 15 hours 24 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 22 hours 29 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/11/2026 at 13:36, 13 minutes ago Vulcan secures second lithium production licence for Lionheart Project
Published on 09/11/2026 at 13:30, 19 minutes ago La Vaudoise construit un nouvel immeuble résidentiel innovant et pose sa première pierre à Zurich
Published on 09/11/2026 at 13:27, 22 minutes ago Turkiye Garanti Bankasi A.S.: CMB Approval for Bond Issuance to Foreign Markets
Published on 09/11/2026 at 13:24, 25 minutes ago EQS-Adhoc: PAUL Tech AG: PAUL Tech AG seeks a two-year extension of the term of the EUR 35 million bond
Published on 09/11/2026 at 13:00, 49 minutes ago Gastech 2026: The Global Energy Industry Arrives in Bangkok as Asia Drives the Next Chapter of Energy Growth
Published on 09/11/2026 at 07:00, 6 hours 49 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 6 hours 49 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 6 hours 49 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 18 hours 19 minutes ago Availability of the 2026 Interim Financial Report
